{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T01:11:14Z","timestamp":1772759474783,"version":"3.50.1"},"reference-count":30,"publisher":"FapUNIFESP (SciELO)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. braz j urol."],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1590\/s1677-55382007000400006","type":"journal-article","created":{"date-parts":[[2007,11,17]],"date-time":"2007-11-17T10:06:34Z","timestamp":1195293994000},"page":"493-501","source":"Crossref","is-referenced-by-count":13,"title":["Double-blind randomized placebo-controlled study of bixa orellana in patients with lower urinary tract symptoms associated to benign prostatic hyperplasia"],"prefix":"10.1590","volume":"33","author":[{"given":"Luis","family":"Zegarra","sequence":"first","affiliation":[{"name":"Peruvian University Cayetano Heredia; National Hospital Cayetano Heredia; Peruvian University Cayetano Heredia, Peru"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abraham","family":"Vaisberg","sequence":"additional","affiliation":[{"name":"Peruvian University Cayetano Heredia; National Hospital Cayetano Heredia; Peruvian University Cayetano Heredia, Peru"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesar","family":"Loza","sequence":"additional","affiliation":[{"name":"Peruvian University Cayetano Heredia; National Hospital Cayetano Heredia; Peruvian University Cayetano Heredia, Peru"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roxana L.","family":"Aguirre","sequence":"additional","affiliation":[{"name":"Peruvian University Cayetano Heredia; National Hospital Cayetano Heredia; Peruvian University Cayetano Heredia, Peru"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Campos","sequence":"additional","affiliation":[{"name":"Peruvian University Cayetano Heredia; National Hospital Cayetano Heredia; Peruvian University Cayetano Heredia, Peru"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irma","family":"Fernandez","sequence":"additional","affiliation":[{"name":"Peruvian University Cayetano Heredia; National Hospital Cayetano Heredia; Peruvian University Cayetano Heredia, Peru"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar","family":"Talla","sequence":"additional","affiliation":[{"name":"Peruvian University Cayetano Heredia; National Hospital Cayetano Heredia; Peruvian University Cayetano Heredia, Peru"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leon","family":"Villegas","sequence":"additional","affiliation":[{"name":"Peruvian University Cayetano Heredia; National Hospital Cayetano Heredia; Peruvian University Cayetano Heredia, Peru"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","series-title":"Enfermedades de la Pr\u00f3stata","first-page":"107","volume-title":"Etiolog\u00eda de la Hiperplasia Prost\u00e1tica Benigna","author":"Lawson RK","year":"1994"},{"key":"ref2","series-title":"Benign Prostatic Hyperplasia","first-page":"3","volume-title":"Epidemioloy and Natural History","author":"Kirby RS","year":"1997"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0090-4295(99)80409-9","article-title":"The Hytrin Community Assessment Trial study: a one-year study of terazosin versus placebo in the treatment of men with symptomatic benign prostatic hyperplasia. HYCAT Investigator Group","volume":"47","author":"Roehrborn CG","year":"1996","journal-title":"Urology","ISSN":"https:\/\/id.crossref.org\/issn\/0090-4295","issn-type":"print"},{"key":"ref4","first-page":"1251","article-title":"Efficacy and safety of finasteride therapy for benign prostatic hyperplasia: results of a 2-year randomized controlled trial (the PROSPECT study). PROscar Safety Plus Efficacy Canadian Two year Study","volume":"155","author":"Nickel JC","year":"1996","journal-title":"CMAJ","ISSN":"https:\/\/id.crossref.org\/issn\/0820-3946","issn-type":"print"},{"key":"ref5","series-title":"Urologe A","first-page":"8","volume-title":"Conservative, non-hormonal treatment of benign prostatic hyperplasia","volume":"29","author":"Dreikorn K","year":"1990"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/01.ju.0000078083.38675.79","article-title":"AUA guideline on management of benign prostatic hyperplasia (2003)","volume":"170","year":"2003","journal-title":"J Urol","ISSN":"https:\/\/id.crossref.org\/issn\/0022-5347","issn-type":"print"},{"key":"ref7","first-page":"143","article-title":"Plant extracts in BPH","volume":"45","author":"Di Silverio F","year":"1993","journal-title":"Minerva Urol Nefrol","ISSN":"https:\/\/id.crossref.org\/issn\/0393-2249","issn-type":"print"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1464-410X.1996.00104.x","article-title":"Phytotherapy for the prostate","volume":"78","author":"Buck AC","year":"1996","journal-title":"Br J Urol","ISSN":"https:\/\/id.crossref.org\/issn\/0007-1331","issn-type":"print"},{"key":"ref9","first-page":"3","article-title":"Alternative Medicine and Benign Prostatic Hyperplasia","author":"Thompson IM","year":"1998","journal-title":"AUA News"},{"key":"ref10","series-title":"Textbook of Benign Prostatic Hiperplasia","first-page":"332","volume-title":"Phytotherapeutic agents","volume":"30","author":"Fitzpatrick JM","year":"1996"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3109\/10601339709019441","article-title":"Saw palmetto berry in the treatment of benign prostatic hyperplasia","volume":"14","author":"Lowe FC","year":"1997","journal-title":"Clin Res Reg Affairs"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0090-4295(98)00664-5","article-title":"Phytotherapy in the treatment of BPH: an update","volume":"53","author":"Lowe FC","year":"1999","journal-title":"Urology","ISSN":"https:\/\/id.crossref.org\/issn\/0090-4295","issn-type":"print"},{"key":"ref13","first-page":"379","article-title":"Serenoa repens (Permixon): A review of its pharmacology and therapeutic efficacy in benign prostatic hyperplasia","volume":"9","author":"Plosker GL","year":"1996","journal-title":"Drugs Aging","ISSN":"https:\/\/id.crossref.org\/issn\/1170-229X","issn-type":"print"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF02550137","article-title":"Usefulness of Cernilton in the treatment of benign prostatic hyperplasia","volume":"28","author":"Dutkiewicz S","year":"1996","journal-title":"Int Urol Nephrol","ISSN":"https:\/\/id.crossref.org\/issn\/0301-1623","issn-type":"print"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1464-410X.1990.tb14962.x","article-title":"Treatment of outflow tract obstruction due to benign prostatic hyperplasia with the pollen extract, cernilton: A double-blind, placebo-controlled study","volume":"66","author":"Buck AC","year":"1990","journal-title":"Br J Urol","ISSN":"https:\/\/id.crossref.org\/issn\/0007-1331","issn-type":"print"},{"key":"ref16","series-title":"Benign prostatic desease","first-page":"109","volume-title":"Alterations in the intraprostatic hormonal metabolism by the pollen extract Cernilton","author":"Tun S","year":"1992"},{"key":"ref17","series-title":"Consejo Provincial de Lima","volume-title":"Diario de Lima (1629 - 1634)","author":"Suardo JA","year":"1935"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/S0022-5347(17)36966-5","article-title":"The American Urological Association symptom index for benign prostatic hyperplasia: The Measurement Committee of the American Urological Association","volume":"148","author":"Barry MJ","year":"1992","journal-title":"J Urol","ISSN":"https:\/\/id.crossref.org\/issn\/0022-5347","issn-type":"print"},{"key":"ref19","series-title":"Clin Pract Guid","volume-title":"Benign Prostatic Hyperplasia: Diagnosis and Treatment","volume":"February","author":"McConnell JD","year":"1994"},{"key":"ref20","series-title":"Medical Management of BPH: view of the Future","author":"Kaplan SA","year":"2003"},{"key":"ref21","first-page":"1","article-title":"Introducci\u00f3n y Conclusiones","volume":"38","author":"Chapple C","year":"2000","journal-title":"Eur Urol","ISSN":"https:\/\/id.crossref.org\/issn\/0302-2838","issn-type":"print"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0022-5347(05)67641-0","article-title":"Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia","volume":"163","author":"Marks LS","year":"2000","journal-title":"J Urol","ISSN":"https:\/\/id.crossref.org\/issn\/0022-5347","issn-type":"print"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0302-2838(02)00066-0","article-title":"Comparison of a phytotherapeutic 23. agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study","volume":"41","author":"Debruyne F","year":"2002","journal-title":"Eur Urol","ISSN":"https:\/\/id.crossref.org\/issn\/0302-2838","issn-type":"print"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJM199608223350801","article-title":"The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia: Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group","volume":"335","author":"Lepor H","year":"1996","journal-title":"N Engl J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0022-5347(01)62536-9","article-title":"The impact of medical therapy on bother due to symptoms, quality of life and global outcome, and factors predicting response: Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group","volume":"160","author":"Lepor H","year":"1998","journal-title":"J Urol","ISSN":"https:\/\/id.crossref.org\/issn\/0022-5347","issn-type":"print"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0090-4295(96)00208-7","article-title":"Safety and efficacy of doxazosin in benign prostatic hyperplasia: a pooled analysis of three double-blind, placebo-controlled studies","volume":"48","author":"Roehrborn CG","year":"1996","journal-title":"Urology","ISSN":"https:\/\/id.crossref.org\/issn\/0090-4295","issn-type":"print"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0090-4295(98)00126-5","article-title":"Phase III multicenter placebo-controlled study of tamsulosin in benign prostatic hyperplasia: Tamsulosin Investigator Group","volume":"51","author":"Lepor H","year":"1998","journal-title":"Urology","ISSN":"https:\/\/id.crossref.org\/issn\/0090-4295","issn-type":"print"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000052399","article-title":"Alpha1-blocker therapy for lower urinary tract symptoms suggestive of benign prostatic obstruction: what are the relevant differences in randomized controlled trials?","volume":"38","author":"De Mey C","year":"2000","journal-title":"Eur Urol","ISSN":"https:\/\/id.crossref.org\/issn\/0302-2838","issn-type":"print"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/00365599309180412","article-title":"Doxazosin treatment in patients with prostatic obstruction: A double-blind placebo-controlled study","volume":"27","author":"Christensen MM","year":"1993","journal-title":"Scand J Urol Nephrol","ISSN":"https:\/\/id.crossref.org\/issn\/0036-5599","issn-type":"print"},{"key":"ref30","series-title":"The Fourth International Consultation of Benign Prostatic Hyperplasia","first-page":"63","volume-title":"The economics of the management of lower urinary tract symptoms and benign prostatic hyperplasia","author":"Holtgrewe HL","year":"1998"}],"container-title":["International braz j urol"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/ibju\/v33n4\/v33n4a06.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,4]],"date-time":"2019-05-04T13:21:21Z","timestamp":1556976081000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1677-55382007000400006&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S1677-55382007000400006"],"URL":"https:\/\/doi.org\/10.1590\/s1677-55382007000400006","relation":{},"ISSN":["1677-5538"],"issn-type":[{"value":"1677-5538","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}